Tariff, inflation, supply-chain, and cyber concerns are built into guidance, but innovation is outpacing those headwinds; Medtronic is taking market share and growing markets because new AFib ablation and pacemaker therapies are safer, faster, and easier for physicians, lowering the treatment threshold and pulling more patients into the therapeutic segment for Medtronic and the broader medical technology sector.